Annual Operating Profit
-$376.74 M
-$125.18 M-49.76%
December 31, 2023
Summary
- As of February 12, 2025, TVTX annual operating income is -$376.74 million, with the most recent change of -$125.18 million (-49.76%) on December 31, 2023.
- During the last 3 years, TVTX annual operating profit has fallen by -$301.37 million (-399.81%).
- TVTX annual operating profit is now -2966388.19% below its all-time high of -$12.70 thousand, reached on February 28, 2011.
Performance
TVTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$56.03 M
+$11.03 M+16.44%
September 30, 2024
Summary
- As of February 12, 2025, TVTX quarterly operating income is -$56.03 million, with the most recent change of +$11.03 million (+16.44%) on September 30, 2024.
- Over the past year, TVTX quarterly operating profit has increased by +$26.81 million (+32.37%).
- TVTX quarterly operating profit is now -1867433.33% below its all-time high of -$3000.00, reached on May 31, 2011.
Performance
TVTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$344.89 M
+$36.56 M+9.58%
September 30, 2024
Summary
- As of February 12, 2025, TVTX TTM operating income is -$344.89 million, with the most recent change of +$36.56 million (+9.58%) on September 30, 2024.
- Over the past year, TVTX TTM operating profit has increased by +$31.85 million (+8.45%).
- TVTX TTM operating profit is now -11125512.90% below its all-time high of -$3100.00, reached on November 30, 2010.
Performance
TVTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
TVTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.8% | +32.4% | +8.4% |
| 3 y3 years | -399.8% | +35.4% | -20.2% |
| 5 y5 years | -448.4% | +35.4% | -20.2% |
TVTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -170.1% | at low | at high | +59.7% | -72.9% | +17.6% |
| 5 y | 5-year | -399.8% | at low | -290.4% | +59.7% | -399.1% | +17.6% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +59.7% | <-9999.0% | +17.6% |
Travere Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$56.03 M(-16.4%) | -$344.89 M(-9.6%) |
| Jun 2024 | - | -$67.05 M(-51.8%) | -$381.45 M(-8.8%) |
| Mar 2024 | - | -$138.98 M(+67.8%) | -$418.35 M(+11.0%) |
| Dec 2023 | -$376.74 M(+49.8%) | -$82.84 M(-10.5%) | -$376.74 M(-1.0%) |
| Sep 2023 | - | -$92.58 M(-10.9%) | -$380.61 M(+2.7%) |
| Jun 2023 | - | -$103.95 M(+6.8%) | -$370.63 M(+13.3%) |
| Mar 2023 | - | -$97.37 M(+12.3%) | -$327.22 M(+14.1%) |
| Dec 2022 | -$251.56 M(+80.3%) | -$86.70 M(+5.0%) | -$286.90 M(-7.2%) |
| Sep 2022 | - | -$82.60 M(+36.4%) | -$309.01 M(+26.5%) |
| Jun 2022 | - | -$60.54 M(+6.1%) | -$244.25 M(+12.3%) |
| Mar 2022 | - | -$57.05 M(-47.6%) | -$217.51 M(+9.1%) |
| Dec 2021 | -$139.50 M(+85.1%) | -$108.81 M(+509.7%) | -$199.43 M(+72.2%) |
| Sep 2021 | - | -$17.85 M(-47.2%) | -$115.83 M(+3.1%) |
| Jun 2021 | - | -$33.81 M(-13.2%) | -$112.33 M(+15.4%) |
| Mar 2021 | - | -$38.96 M(+54.5%) | -$97.35 M(+29.2%) |
| Dec 2020 | -$75.38 M(-24.5%) | -$25.21 M(+75.7%) | -$75.38 M(+9.1%) |
| Sep 2020 | - | -$14.35 M(-23.8%) | -$69.10 M(-6.9%) |
| Jun 2020 | - | -$18.82 M(+10.8%) | -$74.19 M(-16.2%) |
| Mar 2020 | - | -$16.99 M(-10.3%) | -$88.54 M(-10.7%) |
| Dec 2019 | -$99.81 M(+45.3%) | -$18.94 M(-2.6%) | -$99.11 M(+3.0%) |
| Sep 2019 | - | -$19.44 M(-41.4%) | -$96.20 M(+0.5%) |
| Jun 2019 | - | -$33.18 M(+20.4%) | -$95.74 M(+16.8%) |
| Mar 2019 | - | -$27.56 M(+72.0%) | -$81.97 M(+19.3%) |
| Dec 2018 | -$68.69 M(+123.1%) | -$16.02 M(-15.6%) | -$68.69 M(+17.4%) |
| Sep 2018 | - | -$18.98 M(-2.2%) | -$58.52 M(+31.3%) |
| Jun 2018 | - | -$19.40 M(+35.8%) | -$44.58 M(+25.6%) |
| Mar 2018 | - | -$14.29 M(+144.3%) | -$35.49 M(+10.0%) |
| Dec 2017 | -$30.79 M | -$5.85 M(+15.9%) | -$32.27 M(-11.8%) |
| Sep 2017 | - | -$5.05 M(-51.1%) | -$36.59 M(-20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$10.31 M(-6.8%) | -$46.27 M(+3.9%) |
| Mar 2017 | - | -$11.06 M(+8.8%) | -$44.54 M(+14.1%) |
| Dec 2016 | -$38.94 M(+20.7%) | -$10.17 M(-30.9%) | -$39.02 M(+4.6%) |
| Sep 2016 | - | -$14.72 M(+71.4%) | -$37.31 M(+18.6%) |
| Jun 2016 | - | -$8.59 M(+54.9%) | -$31.47 M(+5.9%) |
| Mar 2016 | - | -$5.55 M(-34.4%) | -$29.70 M(-7.9%) |
| Dec 2015 | -$32.26 M(-59.6%) | -$8.45 M(-4.8%) | -$32.26 M(-24.1%) |
| Sep 2015 | - | -$8.88 M(+30.1%) | -$42.51 M(-23.4%) |
| Jun 2015 | - | -$6.82 M(-15.8%) | -$55.49 M(-15.7%) |
| Mar 2015 | - | -$8.10 M(-56.7%) | -$65.85 M(-17.5%) |
| Dec 2014 | -$79.81 M(+222.2%) | -$18.70 M(-14.5%) | -$79.81 M(+8.8%) |
| Sep 2014 | - | -$21.87 M(+27.3%) | -$73.38 M(+29.5%) |
| Jun 2014 | - | -$17.18 M(-22.1%) | -$56.67 M(+27.1%) |
| Mar 2014 | - | -$22.06 M(+79.8%) | -$44.58 M(+82.7%) |
| Dec 2013 | -$24.77 M(-18.1%) | -$12.27 M(+138.0%) | -$24.41 M(+101.0%) |
| Sep 2013 | - | -$5.15 M(+1.1%) | -$12.14 M(+73.7%) |
| Jun 2013 | - | -$5.10 M(+170.5%) | -$6.99 M(+269.0%) |
| Mar 2013 | - | -$1.89 M(>+9900.0%) | -$1.89 M(>+9900.0%) |
| Dec 2012 | -$30.26 M(>+9900.0%) | - | - |
| Nov 2012 | - | -$3200.00(+6.7%) | -$13.00 K(+1.6%) |
| Aug 2012 | - | -$3000.00(0.0%) | -$12.80 K(0.0%) |
| May 2012 | - | -$3000.00(-21.1%) | -$12.80 K(0.0%) |
| Feb 2012 | - | -$3800.00(+26.7%) | -$12.80 K(+1.6%) |
| Feb 2012 | -$12.80 K(+0.8%) | - | - |
| Nov 2011 | - | -$3000.00(0.0%) | -$12.60 K(-0.8%) |
| Aug 2011 | - | -$3000.00(0.0%) | -$12.70 K(+30.9%) |
| May 2011 | - | -$3000.00(-16.7%) | -$9700.00(+44.8%) |
| Feb 2011 | -$12.70 K | -$3600.00(+16.1%) | -$6700.00(+116.1%) |
| Nov 2010 | - | -$3100.00 | -$3100.00 |
FAQ
- What is Travere Therapeutics annual operating income?
- What is the all time high annual operating profit for Travere Therapeutics?
- What is Travere Therapeutics annual operating profit year-on-year change?
- What is Travere Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Travere Therapeutics?
- What is Travere Therapeutics quarterly operating profit year-on-year change?
- What is Travere Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Travere Therapeutics?
- What is Travere Therapeutics TTM operating profit year-on-year change?
What is Travere Therapeutics annual operating income?
The current annual operating profit of TVTX is -$376.74 M
What is the all time high annual operating profit for Travere Therapeutics?
Travere Therapeutics all-time high annual operating income is -$12.70 K
What is Travere Therapeutics annual operating profit year-on-year change?
Over the past year, TVTX annual operating income has changed by -$125.18 M (-49.76%)
What is Travere Therapeutics quarterly operating income?
The current quarterly operating profit of TVTX is -$56.03 M
What is the all time high quarterly operating profit for Travere Therapeutics?
Travere Therapeutics all-time high quarterly operating income is -$3000.00
What is Travere Therapeutics quarterly operating profit year-on-year change?
Over the past year, TVTX quarterly operating income has changed by +$26.81 M (+32.37%)
What is Travere Therapeutics TTM operating income?
The current TTM operating profit of TVTX is -$344.89 M
What is the all time high TTM operating profit for Travere Therapeutics?
Travere Therapeutics all-time high TTM operating income is -$3100.00
What is Travere Therapeutics TTM operating profit year-on-year change?
Over the past year, TVTX TTM operating income has changed by +$31.85 M (+8.45%)